Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2021 Filed Jan 19, 2021 17:00 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 2,761 | $171.18 | $472,639.02 |
DisclosureSEC source: 0001645113-21-000008 · wf-form4_161109361209620.xml · nonDerivative · entry 5 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,266 F4 · price: On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,761 shares in multiple trades at prices ranging from $170.50 to $171.49. The price reported above reflects the weighted average sale price. Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 17:00 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 2,148 | $169.76 | $364,644.48 |
DisclosureSEC source: 0001645113-21-000008 · wf-form4_161109361209620.xml · nonDerivative · entry 4 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,027 F3 · price: On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,148 shares in multiple trades at prices ranging from $169.46 to $170.27. The price reported above reflects the weighted average sale price. Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 17:00 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 800 | $168.80 | $135,043.20 |
DisclosureSEC source: 0001645113-21-000008 · wf-form4_161109361209620.xml · nonDerivative · entry 3 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,175 F2 · price: On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 800 shares in multiple trades at prices ranging from $168.44 to $169.25. The price reported above reflects the weighted average sale price. Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 17:00 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
SaleOrdinary Shares | 2,499 | $167.76 | $419,234.74 |
DisclosureSEC source: 0001645113-21-000008 · wf-form4_161109361209620.xml · nonDerivative · entry 2 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,975 F1 · price: On January 15, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth, Mr. Longsworth sold 2,499 shares in multiple trades at prices ranging from $167.41 to $168.18. The price reported above reflects the weighted average sale price. Mr. Longsworth hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 17:00 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
Exercise / conversionOrdinary Shares | 36,396 | $14.37 | $523,010.52 |
DisclosureSEC source: 0001645113-21-000008 · wf-form4_161109361209620.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:32 UTC |
GROENHUYSEN WILHELMUS CMChief Operating Officer
|
GrantOrdinary Shares | 93 | $50.67 | $4,712.22 |
DisclosureSEC source: 0001645113-21-000002 · wf-form4_161014151569340.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,700 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2020 through December 31, 2020. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2020. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:30 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantOrdinary Shares | 53 | $50.67 | $2,685.46 |
DisclosureSEC source: 0001645113-21-000001 · wf-form4_161014142054692.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,685 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2020 through December 31, 2020. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2020. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 651 | $0.00 Strike: $83.30 | $0.00 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · derivative · entry 6 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,555 Underlying: Ordinary Shares · 651 shares Expires 2029-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 1,833 | $0.00 Strike: $47.56 | $0.00 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · derivative · entry 5 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,831 Underlying: Ordinary Shares · 1,833 shares Expires 2029-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 651 | $156.71 | $102,018.21 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · nonDerivative · entry 4 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,356 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOrdinary Shares | 651 | $83.30 | $54,228.30 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · nonDerivative · entry 3 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 1,833 | $156.71 | $287,249.43 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · nonDerivative · entry 2 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,356 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 23:39 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,833 | $47.56 | $87,177.48 |
DisclosureSEC source: 0001628280-20-017712 · wf-form4_160868035486570.xml · nonDerivative · entry 1 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:38 UTC |
HILLEMAN JERYL LDirector
|
SaleRestricted Stock Units | 2,500 | $166.40 | $416,000.00 |
DisclosureSEC source: 0001628280-20-017711 · wf-form4_160868029605808.xml · nonDerivative · entry 1 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,400 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 103,955 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · derivative · entry 27 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 103,955 shares Expires 2025-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 103,955 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · derivative · entry 26 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,955 Underlying: Ordinary Shares · 103,955 shares Expires 2025-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 400 | $166.08 | $66,431.60 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 25 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,632 F23 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 400 shares in multiple trades at prices ranging from $165.97 to $166.12. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 971 | $164.96 | $160,175.19 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 24 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,032 F22 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 971 shares in multiple trades at prices ranging from $164.52 to $165.35. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 536 | $163.35 | $87,554.53 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 23 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,003 F21 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 536 shares in multiple trades at prices ranging from $163.25 to $163.60. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,700 | $162.35 | $276,000.10 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 22 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,539 F20 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,700 shares in multiple trades at prices ranging from $161.81 to $162.80. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,014 | $161.11 | $646,679.48 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 21 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,239 F19 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 4,014 shares in multiple trades at prices ranging from $160.78 to $161.76. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 11,686 | $160.27 | $1,872,915.22 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 20 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,253 F18 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 11,686 shares in multiple trades at prices ranging from $159.76 to $160.72. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,790 | $159.27 | $762,903.30 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 19 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,939 F17 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 4,790 shares in multiple trades at prices ranging from $158.72 to $159.63. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 10,077 | $158.06 | $1,592,810.93 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 18 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,729 F16 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,077 shares in multiple trades at prices ranging from $157.64 to $158.60. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 23,601 | $157.01 | $3,705,522.21 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 17 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,806 F15 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 23,601 shares in multiple trades at prices ranging from $156.63 to $157.61. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 24,973 | $156.08 | $3,897,860.76 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 16 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,407 F14 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 24,973 shares in multiple trades at prices ranging from $155.63 to $156.62. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 21,207 | $155.23 | $3,292,005.02 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 15 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,380 F13 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 21,207 shares in multiple trades at prices ranging from $154.63 to $155.60. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 103,955 | $22.00 | $2,287,010.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 14 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 200 | $166.17 | $33,234.40 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 13 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,632 F12 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 200 shares in multiple trades at prices ranging from $165.97 to $166.38. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 700 | $165.38 | $115,768.10 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 12 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,832 F11 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 700 shares in multiple trades at prices ranging from $164.90 to $165.75. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 500 | $164.11 | $82,054.50 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 11 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,532 F10 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 500 shares in multiple trades at prices ranging from $163.82 to $164.53. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,300 | $162.97 | $211,859.70 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 10 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,032 F9 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,300 shares in multiple trades at prices ranging from $162.80 to $163.37. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,426 | $162.17 | $231,258.70 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 9 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,332 F8 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 1,426 shares in multiple trades at prices ranging from $161.77 to $162.39. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 3,500 | $160.99 | $563,479.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 8 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,758 F7 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 3,500 shares in multiple trades at prices ranging from $160.70 to $161.38. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 12,092 | $160.25 | $1,937,743.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 7 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,258 F6 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 12,092 shares in multiple trades at prices ranging from $159.68 to $160.68. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,500 | $159.32 | $716,953.50 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 6 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,350 F5 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 4,500 shares in multiple trades at prices ranging from $158.68 to $159.65. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 9,183 | $158.09 | $1,451,777.20 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 5 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,850 F4 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 9,183 shares in multiple trades at prices ranging from $157.64 to $158.52. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 24,656 | $157.04 | $3,871,904.27 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 4 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,033 F3 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 24,656 shares in multiple trades at prices ranging from $156.63 to $157.60. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 24,286 | $156.09 | $3,790,826.03 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 3 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,689 F2 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 24,286 shares in multiple trades at prices ranging from $155.63 to $156.62. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 21,612 | $155.24 | $3,355,046.88 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,975 F1 · price: On December 18, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 21,612 shares in multiple trades at prices ranging from $154.63 to $155.61. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 23:37 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 103,955 | $22.00 | $2,287,010.00 |
DisclosureSEC source: 0001628280-20-017710 · wf-form4_160868024119764.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 21:23 UTC |
Cordova AshleyChief Financial Officer
|
SaleOrdinary Shares | 230 | $117.41 | $27,004.53 |
DisclosureSEC source: 0001645113-20-000158 · wf-form4_160443857426133.xml · nonDerivative · entry 1 Cordova Ashley · CIK 0001822014 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,212 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 10,037 | $0.00 Strike: $11.46 | $0.00 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · derivative · entry 6 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,037 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 5,913 | $0.00 Strike: $14.37 | $0.00 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · derivative · entry 5 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,913 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 14,518 | $0.00 Strike: $7.48 | $0.00 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · derivative · entry 4 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,518 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 10,037 | $11.46 | $115,024.02 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · nonDerivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 5,913 | $14.37 | $84,969.81 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 20:08 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 14,518 | $7.48 | $108,594.64 |
DisclosureSEC source: 0001645113-20-000156 · wf-form4_160408850034942.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Balance reflects corrected total to reflect 11,175 shares sold and reported on Form 4 on June 27, 2019 but not deducted from prior totals. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 18:13 UTC |
Weinberg UriChief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 6,500 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001645113-20-000141 · wf-form4_160133119236559.xml · derivative · entry 6 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Ordinary Shares · 6,500 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 18:13 UTC |
Weinberg UriChief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 8,750 | $0.00 Strike: $11.46 | $0.00 |
DisclosureSEC source: 0001645113-20-000141 · wf-form4_160133119236559.xml · derivative · entry 5 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,750 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.